Compare ARK Genomic Revolution ETF (ARKG) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Teucrium Soybean Fund — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Teucrium Soybean Fund trades at $25.24. Which is the better fit depends on your goals.
| ARKG | SOYB | |
|---|---|---|
Sector | Sector/Thematic | Commodities - Metals/Agriculture |
52-Week High | $43.57 | $25.36 |
52-Week Low | $23.09 | $21.07 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SOYB trades at $25.17, up 0.28% today, with a bullish technical outlook driven by strong moving average signals. The stock shows neutral oscillators but positive momentum from ADX. Recent news highlights potential tailwinds from China's $17 billion U.S. crop purchase pledge, which could benefit agricultural sector stocks. Financial ratios are unavailable in the provided data, limiting fundamental clarity.
The stock's outlook is supported by technical strength and positive sector sentiment, but lacks transparent fundamentals. Risks include reliance on agricultural market volatility and absent financial metrics. Investors should seek updated SEC filings for valuation context amid bullish technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
